The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Osimertinib compared to docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small cell lung cancer.
 
Keke Nie
No Relationships to Disclose
 
Zhongfa Zhang
No Relationships to Disclose
 
Xiao Zou
No Relationships to Disclose
 
Chunling Zhang
No Relationships to Disclose
 
Xingjun Zhuang
No Relationships to Disclose
 
Zhuang Yu
No Relationships to Disclose
 
Ketao Lan
No Relationships to Disclose
 
Youxin Ji
No Relationships to Disclose